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Introduction 
Uremic pneumonitis, known as “uremic 
lung”, is a complication of end stage renal 
disease. It rarely is seen these days in deve-
loped countries due to access to hemodia-
lysis in patients with advanced renal failure. 
Uremic pneumonitis is a clinical entity 
that was described as early as 1955.
1
 Its 
pathophysiology is based on uremia-induced 
increased permeability of pulmonary 
alveolo-capillary interfaces, leading to inter-
stitial and intra-alveolar edema, atelectasis, 
alveolar hemorrhage, and pulmonary hyaline 
membrane formation.
2
 These changes are 
compounded by bleeding diathesis 
secondary to platelet dysfunction in 
advanced renal disease.
3
 The pulmonary 
symptoms and radiographic findings are 
reversible with hemodialysis.  
We describe the clinical presentation and 
management of a patient without prior 
history of kidney disease presenting with 
uremic pneumonitis. 
 
Case Report 
A 23-year-old Hispanic male with an 
uneventful past medical history presented 
with complaints of coughing up blood and 
epistaxis. Symptoms started two weeks prior 
with chest pain which worsened with 
breathing, lying on his back, and coughing. 
It progressed to a productive cough with 
hemoptysis of approximately one spoonful 
of bright red blood daily after about a week. 
He also reported infrequent self-limiting 
episodes of epistaxis.  
 
The patient felt feverish. He had chills 
and sweats for one week. Other symptoms 
included shortness of breath on exertion, 
loss of appetite, fatigue, nausea, and a 
metallic taste in his mouth. He denied rash 
or arthralgias and reported normal urinary 
output.   
He had moved to the United States from 
Mexico about four years prior and served as 
a delivery man for grocery stores for one 
and a half years, then as a construction 
worker for one year, and most recently had 
been mowing lawns for about a year. He 
previously smoked cigarettes and drank 
about six cans of beer daily until 
approximately two years prior to present-
ation. He denied use of illicit drugs. Family 
history was significant for his mother having 
hypertension.  
On physical examination, the patient was 
afebrile. He had tachycardia, a respiratory 
rate of 24 bpm, an oxygen saturation of 97% 
on four liters by nasal cannula, and blood 
pressure of 154/90 mmHg. He had marked 
pallor, was in mild respiratory distress with 
hyperdynamic precordium, and coarse rales 
bilaterally on posterior chest auscultation. 
There was no jugular venous distension, 
pericardial friction rub, stupor, asterixis, or 
peripheral edema.  
At presentation, his blood urea/nitrogen 
was markedly elevated at 218 mg/dl with 
serum creatinine of 41.5 mg/dl. His 
hematocrit was low with hemoglobin of 4.6 
g/dl, and urinalysis showed 4+ proteins, 1+ 
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blood, 2-10 white blood cells, 2-10 red 
blood cells, and urine protein/creatinine ratio 
of 11.4. There were no casts noted. An 
autoimmune work up was inconclusive. 
Blood counts and serum chemistry are listed 
in Tables 1 and 2. 
 
Table 1. Serum chemistry at presentation and days 5 and 10 after initiation of dialysis. 
Variable Reference Range On Evaluation Day 5
* 
Day 10
* 
Sodium
 137-147 mmol/L 129 134 139 
Potassium
 3.5-5.1 mmol/L 3.9 3.1 4.4 
Chloride
 98-110 mmol/L 93 97 104 
CO2 21-30 mmol/L 9 21 27 
Blood Urea Nitrogen 8-20 mg/dl 218 136 38 
Creatinine 0.4-1.24 mg/dl 41.51 24.32 5.76 
Anion Gap 8-12 27 16 8 
eGFR > 60 ml/min/1.73 m
2 
1 2 13 
Magnesium 1.6-2.6 mg/dl 3.2 2.1 2.6 
Phosphorus 2.0-4.0 mg/dl 13.9 7.4 4.0 
*
After patient underwent hemodialysis. 
 
Table 2. Basic hematological profile at presentation. 
Variable Reference Range On Evaluation 
Hematocrit 40-50% 13.4 
Hemoglobin 13.5-16.5 g/dl 4.6 
MCV 80-100 FL 83 
WBC 4.5-11.0 K/UL 14.9 
Platelet 15-400 K/UL 206 
PTT 26.1-37.6 secs 31.9 
INR 0.9-1.1 1.1 
 
An initial chest X-ray showed symmetric 
bilateral air space opacities primarily 
involving the lower lung zones (Figure 1a). 
Non-contrast computed tomography (CT) of 
the chest showed diffuse and somewhat 
symmetric airspace opacities throughout the 
lungs bilaterally with a predominance in the 
lower lobes and relative sparing of the upper 
lobes and along the peripheral margins of 
the lungs (Figure 1b).  
Upon admission, this patient received 
packed red blood cell transfusions and 
hemodialysis was initiated. The initial 
working diagnoses were pulmonary renal 
syndrome and lupus, but a comprehensive 
autoimmune work up was inconclusive.  
Renal ultrasound showed atrophic 
bilateral kidneys. An echocardiogram was 
normal. Blood, sputum, and urine cultures 
remained negative for any growth. A renal 
biopsy showed changes suggestive of end 
stage renal disease and primarily an 
immunologically mediated glomerulo-
nephritis producing a mesangio-prolifer-
ative and focally crescentic type of injury 
(Figure 2).  
The patient’s pulmonary symptoms and 
epistaxis resolved with repeated dialysis, as 
did radiographic evidence of alveolar 
infiltrates (Figure 3). This was more 
consistent with uremic pneumonitis rather 
than the pulmonary renal syndrome. 
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Figure 1. Initial chest x-ray (a) and non-contrast chest CT (b) images at presentation. There was 
extensive diffuse symmetric bilateral air space opacities primarily involving the lower lung zones 
characteristic of diffuse pulmonary hemorrhage. 
 
 
Figure 2. a) Renal biopsy showed a single glomerulus exhibiting a fibroepithelial crescent 
(periodic acid-Schiff-methenamine silver stain, 400x). b) Immunofluorescence stain 
demonstrated irregular deposits of C1q along the basement membrane of capillary loops and 
within mesangial areas (FITC anti-C1q, 400x). 
 
 
Figure 3. Follow-up chest x-ray (a) and non-contrast chest CT images (b) showed bilateral air 
space opacities largely resolved following hemodialysis. 
a b 
a b 
a b 
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Discussion
Uremic pneumonitis, common in the 
pre-dialysis era with frequent references in 
medical literature into the 1940s-1960s, is 
now rare in the developed world with 
improved recognition and care of renal 
disease and access to dialysis. Patients 
typically presented with dyspnea and 
characteristic and sometimes reversible 
radiological “butterfly densities” or “bats-
wing shadows”.4,5  
This syndrome uniting pulmonary 
radiological features and uremia previously 
had been referred to by various names, 
including “pulmonary azotemia”,6 “pul-
monary hyperemia with acidosis”,7 “uremic 
edema”,8 or “fluid lung”.9 It has been 
described in association with uremia 
secondary to severe glomerulonephritis and 
hemolytic-uremic syndrome, although it is 
believed to occur secondary to severe 
uremia from any etiology. Hughes
5
 reported 
on a series of seven cases with characteristic 
radiographic changes several of which 
mirror the findings in our patient, including 
the resolution of opacities following 
dialysis, coupled with hemorrhagic changes 
in the lung, and “focal hemorrhages and 
alveolar albuminous and fibrinous edema”. 
Our patient neither had a prior diagnosis 
of renal dysfunction nor long-standing 
uremic symptoms. However, imaging 
studies and biopsy results indicated chronic 
kidney damage with evidence of glomerulo-
nephritis and glomerulosclerosis, suggesting 
prior untreated or unrecognized renal 
disease.  
In a case series of six patients presenting 
with pulmonary-renal syndrome without 
concomitant destructive pulmonary disease, 
Herman et al.
10
 reported two patients with  
evidence of anti-glomerular basement 
membrane disease consistent with the 
Goodpasture Syndrome. Two had idiopathic 
rapidly progressive glomerulonephritis. One 
had immune complex deposition consistent 
with Systemic Lupus Erythematosus and 
one had vasculitic and immunologic changes 
consistent with Wegener’s granulomatosis.  
Our patient had a mesangio-proliferative 
and focal crescentic glomerulonephritis 
which likely produced end-stage kidney 
disease with severe uremia leading to 
pneumonitis. Severe complications from 
uremia are more likely to be encountered in 
patients with limited access to healthcare. 
Uremic pneumonitis can be protean in 
presentation and could be confused for other 
disease entities such as acute pulmonary 
edema, pneumonia, autoimmune, fungal or 
metastatic disease.
11
 It is important for 
clinicians to consider this rare condition as 
part of their differential diagnosis for 
“butterfly lung” or “bats-wing shadows” in 
the setting of hemoptysis and renal failure.  
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